The team, funded by Kyoto University, say it wants to begin human clinical trials in less than a year.
  • joelfromaus@aussie.zoneEnglish
    17·
    1 jaar geleden

    Toregem’s president Honoka Kiso wrote on the company’s website she had lost teeth due to a bone disease when she was a teenager.

    “I wanted to study the cause of my illness and how to regenerate lost teeth,” she said.

    That’s actually a lot more noble than I expected. They’re aiming to first help those who can’t grow teeth due to genetic before expanding out to people who just have missing teeth.

    • bestnerd@lemmy.worldEnglish
      4·
      1 jaar geleden

      So once the protein is activated does it stop? Or like turn off once it reaches the correct size? Also how does it know which teeth to grow?

      • Patches@sh.itjust.works
        9·
        1 jaar geleden

        You turn into a shark with a conveyor belt of razor sharp teeth. Old ones just ‘fall out’ to be replaced regularly.